This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world.…
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Hungary; a country with more than 100 years of history in pharmaceuticals and a leading regional role in the industry. Regulatory reform post-2008 has seen Hungary weather the storm…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the birthplace of the modern pharmaceutical industry; a country that has transitioned out of economic recession and is now benefiting from its prime geographic position, tradition…
The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the largest pharmaceutical manufacturing base and the second largest pharmaceuticals market by value in the Middle East. Despite recent political upheaval, Egypt is a key growth…
This report is an authoritative assessment of the South African healthcare and pharma markets. It features an exclusive in-depth interview with Dr. Aaron Motsoaledi, South African Minister of Health, as well as with leading figures from both public institutions and private…
The report offers companies, investors, policymakers, and stakeholders crucial insight into a country at the global forefront of healthcare, pharmaceutical and biotechnological innovation. It features an exclusive in-depth interview with Europe’s longest-standing Minister…
Mauritius is in the process of rebranding itself as a business-friendly, technologically advanced hub for the pharma industry that will act as a bridge between Asia and Africa. This report offers companies, investors, policymakers, and stakeholders crucial insight into this…
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the Turkish pharmaceutical industry; an industry with a rich heritage currently striving to find the balance between…
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into the fifth largest territory in the world for pharma manufacturing, a territory with significantly improved capabilities in…
The report offers companies, investors, policymakers, and stakeholders with an interest in healthcare, pharmaceuticals, or life sciences insights into a country already leading the way in Southeast Asia and with the potential to grow further. With a burgeoning middle class…